sábado, 18 de mayo de 2019

HIV Vaccine Awareness Day 2019 | HIV.gov

HIV Vaccine Awareness Day 2019 | HIV.gov

The development and deployment of a safe and effective HIV vaccine would provide long-lasting protection and alleviate the need to depend heavily on prevention methods that require continued access and adherence. Anthony S. Fauci, M.D.,  and Maureen M. Goodenow, Ph.D.

Federal Response Blog Posts
HIV Vaccine Awareness Day 2019
Since the first cases of what would become known as HIV/AIDS were initially reported in 1981, scientists and public health officials have been working to better understand HIV, develop strategies to effectively treat and prevent infection, and bring about an end to the pandemic. This goal will almost certainly require a safe and effective HIV vaccine. 
LEARN MORE
 
The 411 on HIV Vaccine Awareness Day
With this week’s observance of HIV Vaccine Awareness Day on May 18, the HIV.gov team has been thinking about the important efforts to discover and test a safe and effective vaccine against HIV.
LEARN MORE
 
 
National Hepatitis Testing Day – IHS Now Recommends Hepatitis C Testing for All Adult Patients
Millions of Americans have chronic viral hepatitis, and most of them don’t know it. National Hepatitis Testing Day on May 19th is an opportunity to remind health care providers and the public about who should be tested for viral hepatitis.
LEARN MORE
 
Digital Tools Blog Posts
How to Present Social Metrics to Leadership
Make the most of your social media efforts. Check out these tips to help you measure your return on investment and communicate the data effectively to your leadership.
LEARN MORE
 
HIV/AIDS BASICS Blog Posts
NIH Awards Will Advance Development of Vaccines for Sexually Transmitted Infections
NIH’s National Institute of Allergy and Infectious Diseases recently awarded $41.6 million in grants to establish four Cooperative Research Centers focused on developing vaccines to prevent sexually transmitted infections.
LEARN MORE
 
 
NIH Trial Evaluates Long-acting HIV Medication in People Unable to Adhere to Strict Daily Regimens
LATITUDE study compares monthly injectable antiretroviral therapy to daily oral drugs. Read more about the background and purpose of the study.
LEARN MORE

No hay comentarios: